MedTrace Logo

Breath and Blood Ammonia Response to an Oral Protein Challenge

NCT02650245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-10-13

No results posted yet for this study

Summary

The investigators specific aim is to evaluate the changes in breath ammonia in comparison to blood ammonia and other physiologic markers after a moderate oral protein challenge in healthy subjects and subjects with liver cirrhosis.

Conditions

  • Cirrhosis

Interventions

DIETARY_SUPPLEMENT

EAS Myoplex Protein Drink + 10gm lactulose

Sponsors & Collaborators

  • St. Luke's Hospital and Health Network, Pennsylvania

    lead OTHER

Principal Investigators

  • Steve Solga, M.D. · St. Luke's University Hospital and Health Network

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02650245 on ClinicalTrials.gov